Vulnerability in Medtronic Valleylab Exchange Client
CVE-2019-13539
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use the descrypt algorithm for OS password hashing. While interactive, network-based logons are disabled, and attackers can use the other vulnerabilities within this report to obtain local shell access and access these hashes.
EPSS: 0.003 (18.8th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 7.0 (High). Vector: CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H.
Affected products
- Medtronic Valleylab Exchange Client — versions 0
- Medtronic Valleylab_exchange_client
- Medtronic Valleylab_ft10_energy_platform
- Medtronic Valleylab_ft10_energy_platform_firmware
- Medtronic Valleylab Ft10 Energy Platform (Vlft10gen) — versions 0
- Medtronic Valleylab_fx8_energy_platform
- Medtronic Valleylab_fx8_energy_platform_firmware
- Medtronic Valleylab Fx8 Energy Platform (Vlfx8gen) — versions 0
Weakness classification (CWE)
References
- ics-cert@hq.dhs.gov
- ics-cert@hq.dhs.gov
- af854a3a-2127-422b-91ae-364da2661108 (Third Party Advisory, US Government Resource)
Frequently asked questions
- What is CVE-2019-13539?
- CVE-2019-13539 is a high-severity vulnerability in Medtronic Valleylab Exchange Client, classified under Use of Weak Hash. CVSS score: 7.0/10. Published 2019-11-08.
- How severe is CVE-2019-13539?
- High severity. CVSS v3 base score is 7.0 out of 10.